PYRROLOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

发明人:

申请号：

HK15101648.7

公开号：

HK1201256B

申请日:

2015.02.13

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

The ectopic expression of Mer receptor tyrosine kinase (Mer) has been identified as a tumor cell survival gene product in Acute Lymphoblastic Leukemia (ALL) cells and a potential cause of ALL chemoresistance. Hence, we investigated whether the development of small molecule Mer inhibitors was possible. A first aspect of the present invention is a compound (sometimes referred to as an &ldquoactive compound&rdquo herein) of Formula I, IA, or IB.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/